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Abstract: We discuss strategies within the field to restore hearing in the context of a flat epithelia                 
model. This could assist in avoiding the limitations of current treatment options along             
with the obstacles associated with cellular restoration attempts. A review of the important             
genes required for the development, differentiation, and long-term maintenance of the           
organ of Corti (OC) demonstrates that any future direction to regenerate hair cells             
necessitates a better understanding of the gene expression in addition to the cells present              
during the phalangeal scarring process and the flat epithelia environment. This           
understanding could be achieved through the development of a characterized flat           
epithelia, followed by complete regeneration of various sensory cell types in the correct             
location that respond appropriately to noise stimuli. Of course, this strategy would have             
to be modified for the different types and cellular manifestations of hearing loss. The              
characterization of the flat epithelia model and the context of the genes can be further               
manipulated for precise regeneration of a functional OC based on the cellular            




Neurosensory hearing loss is one of the most prevalent sensory disorders,           
with over 5% of the world’s population living with disabling hearing loss [40,             
45]. In the United States alone, one in eight people over the age of 12 experience                
hearing loss in both ears [35], and by age 60, approximately one-third of the              
population has difficulty hearing [40]. Additionally, hearing loss at birth, known           
as congenital hearing loss, is one of the most common chronic disorders in             
children [27]. The hearing loss in these pediatric patients is due to genetic factors.              
However, other causes of hearing loss include noise-induced hearing loss,          
ototoxic drugs, and other environmental insults. In many cases of hearing loss, the             
mechanosensory cells of the inner ear responsible for transforming sound waves           
into electrical impulses are lost. The remaining tissue is characterized by the ‘flat             
epithelia’ leftover when these sensory cells have died [20, 21, 50, 56, 57]. This              
review will discuss leading strategies in the field to restore hearing, including the             
limitations of the current treatment options. We will also discuss previous           
attempts at cellular restoration within the inner ear, and the generation of genetic             
tools in a mouse model that could be vital to design novel treatment options for               
patients. 
 




The inner ear is split into two regions: the vestibular region and the             
cochlea. While the vestibular system provides a sense of balance, the cochlea is             
responsible for the sense of hearing as a result of a highly organized arrangement              
of specific cell types. These cell types can be split into three different categories:              
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the mechanosensory cells responsible for hearing, the supporting cells that help           
maintain these mechanosensory cells, and the spiral ganglion neurons (SGNs) that           
transmit the electrical signal produced by the mechanosensory cells to the           
hindbrain [11, 12, 13, 22, 56​]. These mechanosensory cells are called hair cells.             
While these cells are not like the hair found on top of one’s head, they do have                 
small tufts of stereocilia on their apical surface that resemble small hairs.  
The hair cells and the supporting cells run the entire length of the cochlea              
in a region called the organ of Corti (OC) ​(Figure 1). The cochlea is a long, coiled                 
tube with two ends: the apex and the base. During development, the OC is formed               
as a result of two opposing gradients of gene expression within the cochlea. In              
mice, around embryonic day 12 (E12), the cells that will eventually become the             
hair cells and supporting cells, collectively called prosensory cells, exit the cell            
cycle in the apex of the cochlea. These prosensory cells will continue to             
progressively exit the cell cycle towards the base until around E14. At E13.5, hair              
cells start to differentiate within the mid-base, which spreads to the apex and the              
far basal region over the next 3-4 days [14, 19, 30, 60].  
In addition to these developmental gradients, an important distinction         
between the basal and apical sections of the cochlea is that the hair cells in these                
regions respond to different frequencies of sound. The cochlear base responds           
best to high-frequency waves, while the cochlear apex optimally responds to           
low-frequency waves [19, 60]. The SGNs that synapse onto hair cells in the base,              
mid-base, and apex help establish a tonotopic map in the hindbrain that directly             
corresponds to this gradient of frequencies [21, 22, 38, 71]. In cases of age-related              
hearing loss, most people first lose their sense of hearing in the region of higher               
frequencies before the hearing loss eventually progresses to the lower frequencies           
[28]. As such, the main function of hair cells is to respond to the physical               
movement of the stereocilia on their surface in order to release neurotransmitters            
to SGNs for sound transduction.  
There are four rows of hair cells in the OC: one row of inner hair cells and                 
three rows of outer hair cells (Figure 2).  
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The two types of hair cells are connected to two categories of SGNs, Type I SGNs                
and Type II SGNs, in order to serve two specific functions. Inner hair cells are               
connected to the Type I SGNs and are responsible for the transduction of sound              
information that will be consciously perceived, while the Type II SGNs synapse            
on the outer hair cells and are involved in a modulatory feedback loop [21, 22,               
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38]. Regardless of their function, both hair cell types are braced by five different              
types of supporting cells: inner and outer pillar cells, inner and outer phalangeal             
cells, and border cells. The inner and outer pillar cells delineate respectively the             
inner and outer hair cells and form a cavity within the OC, called the tunnel of                
Corti, filled with a sodium-rich and potassium-poor extracellular fluid known as           
perilymph [19, 73]. Perilymph is different from the potassium-rich and          
sodium-poor extracellular fluid that comes into direct contact with the stereocilia           
of the hair cell, which is known as endolymph. The ion composition of             
endolymph is so unique that it is not found elsewhere in the body, while the ion                
composition of perilymph is very similar to other extracellular fluids [73]. The            
strict segregation of these two fluids between the stereocilia and the body of both              
hair cell types is important for establishing the sensitive ion gradient required for             
both types of SGNs to fire electrical signals to the hindbrain. The bodies of inner               
hair cells come into contact with the perilymph because they are supported within             
the inner phalangeal cells. Likewise, the bodies of outer hair cells sit within the              
outer phalangeal cells. However, the stereocilia on the apical surface of both hair             
cell types come into contact with endolymph [19, 73].  
The OC is sandwiched between two nonsensory regions called the greater           
epithelial ridge (GER) and the lesser epithelial ridge (LER). The inner and outer             
border cells delineate the sensory cells in the OC from the nonsensory GER and              
LER, respectively. The GER contains inner sulcus cells, while the LER contains            
the outer sulcus cells. As the name suggests, the single row of inner hair cells               
(IHCs) lies closest to the GER, while the three rows of outer hair cells (OHCs) lay                
closest to the LER. Together, the hair cells and supporting cells comprise the             
sensory region and are grouped as sensory cells, while the cells within the GER              
and LER are considered non-sensory (Figure 2).  
The specific organization of the cells within the OC can be further            
visualized by immunohistochemistry ​for cell-specific proteins (​Figure 2​)​. The         
single row of IHCs and the three rows of OHCs can be seen via the Myosin VIIA                 
antibody, which only labels hair cells. The actin stain Phalloidin binds to the             
stereocilia on the top of the hair cells. The merged image demonstrates how the              
hair cells are organized by type and stereocilia arrangement. Furthermore, the           
Sox2 antibody will bind to all supporting cells underneath the hair cells in order              
to visualize the bottom supporting layer of the OC. Together, these           
immunohistochemistry images establish a complete picture of the sensory cell          
types in the OC. 
 
Histological Effects During Hearing Loss 
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Complete hearing loss is characterized by the presence of a flat epithelia            
absent of all sensory cells (Figure 3). After the sensory hair cells die, the inner               
and outer phalangeal cells expand to replace them. This process is called            
phalangeal scarring [21, 56, 57]. After phalangeal scar formation, all the sensory            
supporting cells are replaced by a flat environment caused when the GER and             
LER come together to fill this gap. The name ‘flat epithelia’ is inspired by the               
cellular morphology of the flat inner and outer sulcus cells from these regions             
joining together. Previous studies have shown that the process of creating a flat             
epithelium can range from a few days to several months [26, 57, 70]. This cellular               
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environment has not been well-characterized, but it could be pivotal in hearing            
restoration studies since it is the phenotype seen in many hearing loss patients [14,              
20, 21, 56, 57, 70]. Gene expression is strictly maintained in the GER and LER               
and can be visualized via ​in situ ​hybridization for the genes ​Fgf10 and ​Bmp4​,              
respectively (Figure 3) [34, 52]. Previous studies have attempted to regenerate           
hair cells by converting supporting cells or nearby non-sensory GER cells into            
hair cells through the ectopic expression of genes known to be important for hair              
cell formation [1, 5, 24, 36, 42]. However, as shown in Figure 3, there are no                
differentiated supporting cell types within the flat epithelia, and because of this,            
these approaches would not easily translate into an effective treatment option for            
hearing loss.  
Aside from gene therapy, an alternative approach to treat hearing loss is            
the injection of cells into the inner ear with the expectation that they would              
survive and proliferate into sensory cells after the addition of prosensory factors.            
The field of regenerative medicine has a history of using stem cells in order to               
regenerate tissues, but the cochlea poses a unique problem due to the extracellular             
fluid that comes into contact with the OC. First, the endolymph creates a toxic              
environment for any non-native cell types due to the high potassium           
concentration. Second, there is no stem cell niche in the inner ear. As a result,               
previous studies have shown that human embryonic stem cells did not survive            
more than one day post-injection into the inner ear [32, 46]. Other studies             
attempted to inject HeLa cells into the ear due to their more robust nature and               
potential to survive in this hostile cellular environment. While these cells survived            
up to a week post-injection, these studies were also unsuccessful [31, 32, 50].             
Another study attempted to inject neural stem cells into the cochlea with the             
intention to generate functional SGNs. A small number of cells were generated            
that resembled satellite cells and Type I SGNs, but these were not maintained             
long-term [51]. These studies reiterated the specificity of the toxic          
micro-environment of the cochlea to non-native cells but also demonstrated that           
the cochlea might provide signals for the differentiation of the various cell types.             
Due to this unique problem, current approaches in the field to treat hearing loss              







A novel approach to treat hearing loss is the use of gene therapy in order to                
generate functional hair cells. Studying the development of the cochlea in a            
mouse model allows for the identification of genes necessary to generate hair cells             
normally. This is especially important due to the lack of a stem cell niche to study                
in the inner ear. Therefore, genes discovered in these studies can be manipulated             
in order to generate new hair cells in hearing loss models. Previous studies have              
identified several transcription factors that influence the development of different          
cell types in the OC. ​Atoh1​, a basic helix-loop-helix (bHLH) transcription factor,            
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is found to be necessary for the differentiation of ​both inner and outer hair cells               
(Figure 4) [5, 6, 75]. Due to its essential role within hair cells, ​Atoh1 has been the                 
primary gene of interest for several studies attempting to regenerate hair cells [5,             
6, 24, 36, 47, 48, 75]. Furthermore, ​Atoh1 lends itself to manipulation because it              
has two different enhancers and auto-regulates its own expression by binding to            
one of its own enhancers [47, 48]. Another important transcription factor called            
Sox2 is expressed in all the supporting cell types discussed in Figure 2, including              
the inner and outer border cells, phalangeal cells, and pillar cells. It has also been               
shown that the SOX2 protein acts in a physical complex with EYA1 and SIX1 in               
order to regulate ATOH1 expression in the hair cells by physically binding to the              
second ​Atoh1 enhancer [1, 12, 55]. This suggests that ​Atoh1 and ​Sox2 may work              
together in order to create the specific organization of hair cells and supporting             
cells. However, it is not that simple. Other studies have demonstrated that            
Delta-Notch signaling regulates expression of ​Hes/Hey genes that may also play a            
role in determining the specific patterning between hair cells and supporting cells            
[4, 8, 42, 53].  
In addition, previous studies have shown that there are other transcription           
factors required for long-term maintenance of sensory cell types. For example, the            
zinc-finger transcription factor called ​Gata3 is particularly interesting due to the           
variance in its expression throughout both embryonic and postnatal development          
[9, 10, 23, 34]. ​Gata3 is highly expressed alongside ​Sox2 in the supporting cells,              
but both types of hair cells have low residual levels of ​Gata3 expression at              
postnatal day 0 (P0) [34, 75]. While ​Gata3 is originally expressed in both the              
GER and LER in early embryonic development, it is important to note that ​Gata3              
is not expressed in these regions at P0. Because ​Gata3 is expressed in multiple              
cell types at the early stages of development, but is highly restricted later on, it               
has been suggested that ​Gata3 may be modifying the expression of other            
transcription factors for the long-term survival of sensory cell types [21]. 
As previously mentioned, without SGN presents, these cell types will not           
be functional. ​NeuroD1​, a bHLH transcription factor in the same family as ​Atoh1​,             
is specifically expressed in the SGNs that synapse onto these hair cells [21, 22,              
38, 49]. It is vital to note that bHLH transcription factors often form complex              
regulatory networks in sensory systems, which is especially true in the ear [66].             
Since ​NeuroD1 represses ​Atoh1 expression within SGNs, there is a negative           
feedback loop between these two transcription factors in the ear [49]. It has been              
suggested that the expression of ​NeuroD1 and the subsequent downregulation of           
Atoh1 is key in determining which prosensory cells will become SGNs instead of             
hair cells, or vice versa [11, 13, 43]. Expression of ​Atoh1 is still required for               
proneurosensory cells to develop [5]. Another bHLH transcription factor,         
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Neurog1​, has a strong regulatory role and also seems to play an overlapping role              
with ​Atoh1 in the ear. Early in development, at E 9.5, the prosensory progenitor              
cells that will eventually become SGNs express ​Neurog1​, and previous studies           
have reported that ​Neurog1 expression increases the progenitor population and          
cell expansion [37, 67, 71]. Interestingly, in the absence of ​Atoh1 or ​Neurog1             
expression, no hair cells or SGNs form [5, 37]. It has also been shown that the                
replacement of one ​Atoh1 gene with the ​Neurog1 ​gene will partially rescue this             
phenotype, implying that these two transcription factors play a similar role even if             
they are not a complete substitute for each other. While ​Neurog1 has a regulatory              
role in order to increase the proneurosensory progenitor cells, it also acts in a              
network with ​NeuroD1 and ​Atoh1 in order to influence which cells ultimately            
become SGNs or hair cells. In conclusion, hair cell formation requires a network             
of several transcription factors throughout development combined with different         
gene expression gradients that are eventually restricted to certain cell types.  
 
Current Treatment Options 
 
There are typically only two types of treatment available to patients who            
suffer from hearing loss: cochlear implants and hearing aids. Cochlear implants           
do not rely on the hair cells, but rather directly stimulate the SGNs that relay               
sound information from the ear to the hindbrain. These SGNs make up part of              
cranial nerve VIII [78]. In order to work, cochlear implants require at least some              
functional SGNs [72]. Interestingly, it has been shown in previous studies that            
SGNs require support from the hair for survival [3, 29, 69, 71]. As a result, SGNs                
may be lost long-term in patients with cochlear implants, rendering this treatment            
a temporary one. Another practical limitation of cochlear implants includes the           
lack of perception of music. While patients with cochlear implants can           
comprehend speech and detect simple rhythms under normal hearing conditions,          
this technology does not appropriately account for the perception of pitch, timbre,            
or melody recognition [41]. Most patients who utilize cochlear implants report           
that they no longer find the sound of music as enjoyable or maintain their personal               
genre preference [41].  
In contrast to cochlear implants, hearing aids amplify the sound to assist            
with partial hearing loss, but they still require at least a small population of              
functional hair cells in addition to SGNs in order for sound to be relayed to the                
brain and interpreted [18, 33, 40] While this treatment option does allow patients             
to listen to music, the use of hearing aids carries a heavy social stigma along with                
limitations in noisy environments. This prevents most people who need hearing           
aids from actually using them. Previous studies have reported that almost 80% of             
people aged 54-70 who need hearing aids intentionally choose not to use them             
[40]. Further investigations have shown that these patients attribute external          
societal pressures in the media, self-perceived judgment, and struggles with          
ageism and vanity as reasons for declining this treatment option [74]. ​ The             
problem of hearing loss and lack of effective treatments is further compounded            
by the increase in average lifespan and continued rapid growth in the aging             
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population[14, 44]. Therefore, the regeneration of sensory hair cells would be           
preferable to the currently available treatment options.  
 
Flat Epithelial Models of Hearing Loss  
 
 
Based on previous studies and other attempts to restore hearing, gene           
manipulation within the flat epithelia seems to have the most potential for the             
successful regeneration of hair cells. All types of hearing loss are characterized by             
the loss of sensory cells, which results in a flat epithelium. However, in order to               
perform experiments within a flat epithelia model, the model itself must be            
characterized. There are two methods to create a flat epithelium: 1) the            
Pou4f3-DTR genetic mouse line and 2) antibiotic exposure. Uniquely, mice are           
immune to diphtheria because their cells do not have the receptor on the plasma              
membrane for the diphtheria toxin (DTX). ​Pou4f3 is a gene that is expressed early              
in hair cell development (Figure 5). In this genetic model, the cells that express              
Pou4f3 will also express the human receptor for the diphtheria toxin. After            
injection with DTX, only the hair cells will die because only these cells within the               
inner ear express the receptor [16, 62]. Using this technique to target the hair cells               
specifically is similar to the method in the paper that first reported phalangeal             
scarring [26, 50, 56, 57, 62]. The supporting cells are unharmed but are destroyed              
as the enlarged phalangeal scars are replaced by the inner and outer sulcus cells of               
the GER and LER, respectively. Characterization of the gene expression and cell            
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types in the flat epithelia will be possible since this model is easily repeated with               
a single DTX injection. However, another option to create the flat epithelia is to              
inject with antibiotics that have been shown to have ototoxic properties. For            
example, gentamicin and neomycin are commonly-prescribed antibiotics, but both         
have been shown to kill hair cells and sensory cells in the cochlea after high doses                
or prolonged use ​[17, 58, 64, 76, 77]. Additionally, commonly-prescribed          
chemotherapeutic drugs like cisplatin have also demonstrated ototoxicity at high          
levels and after long-term use [61, 65]. The advantage of the diphtheria injection             
model is that it should affect all the hair cells of the OC, while the model created                 
through antibiotics can be patchy in the OC or have different effects that change              
along the length of the cochlea. 
Once the field has a more complete understanding of the flat epithelia,            
gene manipulation in this environment will be the next step in order to regenerate              
a functional OC. One gene that may be important in altering the flat epithelia of               
hearing loss patients is ​Gata3 (Figure 5). As previously described, ​Gata3 is            
widely expressed throughout the early development of the ear, but it becomes            
restricted at P0 and later ages [9, 10]. It is known that differential levels of               
transcription factors determine the level of their function, which raises another           
interesting question: why does ​Gata3 have varying levels of expression          
throughout the ear? The implication is that ​Gata3 either has several different roles             
throughout development or that ​Gata3 plays a specific role that is restricted to             
certain prosensory regions as the cells within the ear differentiate. One way to             
tease these questions apart is to determine the effects of ​Gata3 within the flat              
epithelia. It has been previously shown that there is a constant low level of ​Gata3               
expression in cells that border the OC within the GER and LER, which would be               
present in a flat epithelia disease model created from either the DTR approach or              
the antibiotic method [57]. Furthermore, ​Gata3 has been shown to be necessary            
for the proper function of ATOH1, both initially and long-term [10, 75].            
Regarding the second method, it has been previously suggested that          
overexpression of ​Gata3 may have a protective function against antibiotic          
ototoxicity because of its role in long-term maintenance of ectopic and           
regenerated hair cells. Regardless of the method, the field will benefit from the             
complete characterization of the flat epithelia model, with and without phalangeal           
scarring. Furthermore, a more complete understanding of the role of ​Gata3 in the             
development and long-term maintenance of sensory cell types in the OC can            




This paper discussed strategies within the field to restore hearing in the            
context of a flat epithelia model that could alleviate the limitations of current             
treatment options and avoid the obstacles associated with cellular restoration          
attempts. A review of important genes required for the development,          
differentiation, and long-term maintenance of the OC demonstrates that any future           
direction to regenerate hair cells necessitates a better understanding of the gene            
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expression as a whole. Specifically, regeneration of hair cells requires a more            
complete understanding of the genes and cells present during the phalangeal           
scarring process and within the resulting flat epithelia environment. As previously           
suggested, this understanding could be achieved through the development of a           
characterized flat epithelia, followed by complete regeneration of various sensory          
cell types in the correct location that respond appropriately to noise stimuli [21].             
Future directions will likely focus on the manipulation of genes that influence hair             
cell development, for example, ​Gata3​, within this flat environment. This          
knowledge will assist in the design of treatments for hearing loss that does not              
require certain cell types, like cochlear implants or hearing aids. Furthermore,           
these novel treatment options can target the flat epithelia remaining in all types of              
hearing loss.  
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